These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9617720)
1. Quality of life and Parkinson's disease: the CR FIRST Study. Wasielewski PG; Koller WC J Neurol; 1998 May; 245 Suppl 1():S28-30. PubMed ID: 9617720 [TBL] [Abstract][Full Text] [Related]
2. Quality of life in patients with Parkinson's disease who transfer from standard levodopa to Sinemet CR: the STAR Study. The STAR Multicenter Study Group. Grandas F; Martínez-Martín P; Linazasoro G J Neurol; 1998 May; 245 Suppl 1():S31-3. PubMed ID: 9617721 [TBL] [Abstract][Full Text] [Related]
3. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group. Block G; Liss C; Reines S; Irr J; Nibbelink D Eur Neurol; 1997; 37(1):23-7. PubMed ID: 9018028 [TBL] [Abstract][Full Text] [Related]
4. Sinemet CR in Parkinson's disease. Pfeiffer RF; Wilken KE; Glaeske CS; Hofman R Nebr Med J; 1991 Jan; 76(1):8-10. PubMed ID: 1997878 [TBL] [Abstract][Full Text] [Related]
5. Results of long-term treatment with controlled-release levodopa/carbidopa (Sinemet CR). Cedarbaum JM; Silvestri M; Clark M; Toy L; Harts A; Green-Parsons A; McDowell FH J Neural Transm Park Dis Dement Sect; 1990; 2(3):205-13. PubMed ID: 2257060 [TBL] [Abstract][Full Text] [Related]
6. Controlled-release Sinemet (CR-4): a double-blind crossover study in patients with fluctuating Parkinson's disease. Ahlskog JE; Muenter MD; McManis PG; Bell GN; Bailey PA Mayo Clin Proc; 1988 Sep; 63(9):876-86. PubMed ID: 3045435 [TBL] [Abstract][Full Text] [Related]
7. Comparison of controlled-release Sinemet (CR4) and standard Sinemet (25 mg/100 mg) in advanced Parkinson's disease: a double-blind, crossover study. Sage JI; Mark MH Clin Neuropharmacol; 1988 Apr; 11(2):174-9. PubMed ID: 3378226 [No Abstract] [Full Text] [Related]
8. Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet). Goetz CG; Tanner CM; Klawans HL; Shannon KM; Carroll VS Neurology; 1987 May; 37(5):875-8. PubMed ID: 3574696 [TBL] [Abstract][Full Text] [Related]
9. Sinemet CR in the treatment of patients with Parkinson's disease already on long-term treatment with levodopa. Aarli JA; Gilhus NE Neurology; 1989 Nov; 39(11 Suppl 2):82-5; discussion 95. PubMed ID: 2586767 [TBL] [Abstract][Full Text] [Related]